A Phase Ib/II Clinical Trial to Evaluate the Safety and Efficacy of JL15003 Injection in Patients With Recurrent Glioblastoma (rGBM)
NCT07501559 · Status: RECRUITING · Phase: PHASE1/PHASE2 · Type: INTERVENTIONAL · Enrollment: 40
Last updated 2026-03-30
Summary
The goal of this clinical trial is to evaluate the safety and efficacy of JL15003 Injection in subjects with recurrent glioblastoma (rGMB).
Conditions
- Recurrent Glioblastoma Multiforme(GBM)
Interventions
- BIOLOGICAL
-
JL15003Injection
Intratumoral or intracavitary administration of JL15003 Injection as needed
Sponsors & Collaborators
-
Jecho Biopharmaceuticals Co., Ltd.
lead INDUSTRY
Study Design
- Allocation
- NA
- Purpose
- TREATMENT
- Masking
- NONE
- Model
- SINGLE_GROUP
Eligibility
- Min Age
- 18 Years
- Sex
- ALL
- Healthy Volunteers
- No
Timeline & Regulatory
- Start
- 2026-04-30
- Primary Completion
- 2030-04-30
- Completion
- 2030-04-30
Countries
- China
Study Locations
More Related Trials
-
The Safety and Efficacy of SNC-109 CAR-T Cells Therapy the rGBM
NCT06616727 ·Status: ENROLLING_BY_INVITATION ·Phase: PHASE1
-
Studies of Chlorogenic Acid for Injection for Safety and Efficacy of Grade IV GBM Patients
NCT03758014 ·Status: UNKNOWN ·Phase: PHASE2/PHASE3
-
Neoadjuvant PD-1 Antibody Alone or Combined With DC Vaccines for Recurrent Glioblastoma
NCT04888611 ·Status: UNKNOWN ·Phase: PHASE2
-
IL13Rα2 CAR-T Cells Secreting Anti-PD-L1 Antibody for Recurrent Malignant Glioma
NCT07481721 ·Status: NOT_YET_RECRUITING ·Phase: PHASE1
-
A Study of Intra-tumoral Administered MTX110 in Patients With Recurrent Glioblastoma
NCT05324501 ·Status: TERMINATED ·Phase: PHASE1
-
A Phase 2 Study of BGJ398 in Patients With Recurrent GBM
NCT01975701 ·Status: COMPLETED ·Phase: PHASE2
-
XS005 Injection Combined With Stupp Regimen for Adjuvant Chemotherapy in Subjects With Primary Glioblastoma(GBM)
NCT06147505 ·Status: SUSPENDED ·Phase: PHASE1/PHASE2
-
A Study of BL-B01D1 in Patients With Recurrent Glioblastoma
NCT06598787 ·Status: RECRUITING ·Phase: PHASE2
-
Safety, Tolerability and Efficacy of JCXH-211 in Patients With Recurrent or Progressive High-Grade Glioma
NCT06468605 ·Status: WITHDRAWN ·Phase: PHASE1
-
Treatment of Recurrent Glioblastoma With Fractionated Radiotherapy Combined With Cadonilimab
NCT05737368 ·Status: UNKNOWN ·Phase: PHASE1
-
Safety and Tolerability Study of Recombinant L-IFN Adenovirus Injection in Patients With Recurrent Glioblastoma
NCT05914935 ·Status: UNKNOWN ·Phase: EARLY_PHASE1
-
The Efficacy and Safety of Low-dose Radiotherapy Combined With Sintilimab and Temozolomide in Recurrent Glioblastoma
NCT06220552 ·Status: RECRUITING ·Phase: PHASE2
-
A Study of MEDI-575 in Subjects With Recurrent Glioblastoma Multiforme
NCT01268566 ·Status: COMPLETED ·Phase: PHASE2
-
A Safety Study of RTA 744 in Patients With Recurrent High-Grade Gliomas
NCT00526812 ·Status: COMPLETED ·Phase: PHASE1
-
Glufosfamide in Treating Patients With Recurrent Glioblastoma Multiforme
NCT00014300 ·Status: COMPLETED ·Phase: PHASE2
-
Safety and Efficacy of TRPP Therapy in Glioblastoma Multiforme
NCT05589961 ·Status: UNKNOWN ·Phase: EARLY_PHASE1
-
B7-H3 Chimeric Antigen Receptor T Cells (B7-H3CART) in Recurrent Glioblastoma Multiforme
NCT05474378 ·Status: RECRUITING ·Phase: PHASE1
-
HMPL-813 in Treating Patients With Glioblastoma
NCT03231501 ·Status: UNKNOWN ·Phase: PHASE1
-
NBI-3001 Followed by Surgery in Treating Patients With Recurrent Glioblastoma Multiforme
NCT00014677 ·Status: COMPLETED ·Phase: PHASE2
-
To Evaluate the Efficacy and Safety of CAN008 Combined With Re-irradiation (rRT) for Treating Patients With Recurrent Glioblastoma (GBM)
NCT03746288 ·Status: UNKNOWN ·Phase: PHASE2
-
Safety and Efficacy of NRG-103 Injection in the Treatment of Recurrent Glioblastoma Patients
NCT06757153 ·Status: RECRUITING ·Phase: EARLY_PHASE1
-
Bispecific Antibody Plus White Blood Cells in Treating Patients With Recurrent or Refractory Glioblastoma Multiforme
NCT00005813 ·Status: COMPLETED ·Phase: PHASE1
-
A Study to Evaluate the Safety, Tolerance and Initial Efficacy of EGFRvIII CAR-T on Glioblastoma
NCT05802693 ·Status: NOT_YET_RECRUITING ·Phase: EARLY_PHASE1
-
A Study of VRT106 for Injection in Patients With Recurrent/Progressive Glioblastoma
NCT07093814 ·Status: RECRUITING ·Phase: PHASE1/PHASE2
-
A Dose Finding Study of [177Lu]Lu-DOTA-TATE in Newly Diagnosed Glioblastoma in Combination With Standard of Care and in Recurrent Glioblastoma as a Single Agent.
NCT05109728 ·Status: ACTIVE_NOT_RECRUITING ·Phase: PHASE1